| A non-genetic mechanism involving the integrin β4/paxillin axis contributes to chemoresistance in lung cancer A Mohanty, A Nam, A Pozhitkov, L Yang, S Srivastava, A Nathan, X Wu, ... Iscience 23 (9), 2020 | 32 | 2020 |
| EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma YHC Tan, S Srivastava, BM Won, R Kanteti, Q Arif, AN Husain, H Li, ... Oncogenesis 8 (9), 49, 2019 | 24 | 2019 |
| Muscleblind-like 1 and muscleblind-like 3 depletion synergistically enhances myotonia by altering Clc-1 RNA translation J Choi, KE Personius, M DiFranco, W Dansithong, C Yu, S Srivastava, ... EBioMedicine 2 (9), 1034-1047, 2015 | 21 | 2015 |
| Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics S Srivastava, A Mohanty, A Nam, S Singhal, R Salgia Seminars in cancer biology 86, 233-246, 2022 | 20 | 2022 |
| Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy. A Nam, A Mohanty, S Bhattacharya, S Kotnala, S Achuthan, K Hari, ... Biomolecules 12 (8), 1-20, 2021 | 15 | 2021 |
| Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer A Mohanty, A Nam, S Srivastava, J Jones, B Lomenick, SS Singhal, L Guo, ... Science Advances 9 (41), eade3816, 2023 | 14 | 2023 |
| Protein phosphatase 2A as a therapeutic target in small cell lung cancer Molecular Cancer Therapeutics, 2021 | 14 | 2021 |
| Successive phosphorylation of p27KIP1 protein at serine-10 and C terminus crucially controls its potency to inactivate Cdk2 AR Mohanty, Q Kan, S Srivastava, B Uranbileg, S Arakawa-Takeuchi, ... Journal of Biological Chemistry 287 (26), 21757-21764, 2012 | 12 | 2012 |
| Activation of EPHA2-ROBO1 heterodimer by SLIT2 attenuates non-canonical signaling and proliferation in squamous cell carcinomas S Srivastava, KM Pang, M Iida, MS Nelson, J Liu, A Nam, J Wang, ... Iscience 23 (11), 2020 | 9 | 2020 |
| Monitoring and determining mitochondrial network parameters in live lung cancer cells T Mirzapoiazova, H Li, A Nathan, S Srivstava, MW Nasser, F Lennon, ... Journal of clinical medicine 8 (10), 1723, 2019 | 9 | 2019 |
| A human embryonic stem cell model of Aβ-dependent chronic progressive neurodegeneration T Ubina, M Magallanes, S Srivastava, CD Warden, JK Yee, PM Salvaterra Frontiers in Neuroscience 13, 1007, 2019 | 8 | 2019 |
| Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors L Guo, A Mohanty, S Singhal, S Srivastava, A Nam, C Warden, ... Iscience 26 (8), 2023 | 7 | 2023 |
| Targeting the mercapturic acid pathway for the treatment of melanoma SS Singhal, S Srivastava, T Mirzapoiazova, D Horne, S Awasthi, R Salgia Cancer Letters 518, 10-22, 2021 | 7 | 2021 |
| A Non-genetic Mechanism for Chemoresistance in Lung Cancer: The Role of Integrin β4/Paxillin Axis A Mohanty, A Nam, A Pozhitkov, S Bhattacharya, L Yang, A Nathan, X Wu, ... bioRxiv, 781807, 2019 | 5 | 2019 |
| Zebrafish: A prominent tool for cancer drug screening and discovery S Srivastava, L Guo, A Mohanty, M Nelson, B Armstrong, P Kulkarni, ... Cancer Research 80 (16_Supplement), 6130-6130, 2020 | | 2020 |
| Carfilzomib: A potential drug against cisplatin-resistant lung adenocarcinoma A Nam, A Mohanty, S Bhattacharya, S Srivastava, R Pangeni, D Raz, ... Cancer Research 80 (16_Supplement), 6329-6329, 2020 | | 2020 |
| The Ephrin receptor A2 and Roundabout Guidance Receptor 1 heterodimer: A potential theranostic for squamous cell carcinomas KM Pang, S Srivastava, M Iida, M Nelson, J Liu, A Nam, J Wang, ... bioRxiv, 2020.04. 09.034405, 2020 | | 2020 |
| Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation S Srivastava, DM Dixon, DB Bhatt, L Comai, JL Vergara, S Reddy | | 2015 |
| Role of mammalian target of rapamycin complex 1 pathway and extracellular signal regulated kinase pathway in regulating the activating phosphorylation of Cdk4 and Cdk6 S Srivastava 東京大学, 2012 | | 2012 |
| Dynamic Phenotypic Switching and Group Behavior Help Cancer Cells Evade Chemotherapy A Nam, A Mohanty, S Bhattacharya, S Kotnala, S Achuthan, K Hari, ... | | |
